Glycobiology Market Size is estimated to grow at a CAGR of 13.4% during the forecast period
By 2030, the global
glycobiology market, which is currently valued at USD 1,763.8
million, is expected to have grown to USD 4,823.5 million, with a Compound
Annual Growth Rate (CAGR) of 13.4% from 2022 to 2030. The market for
glycobiology is fueled by a number of important aspects that are fostering its
expansion and growth. Rapid technological breakthroughs in the area of glycan
analysis are one of the main motivators. As a result, it is now possible to
examine the structure and function of glycans with higher accuracy, which has
improved our knowledge of how glycans act in a variety of biological processes.
The rising costs and financing for R&D are another
important driver driving the glycobiology industry. The development of novel
technologies and applications in the sector is receiving a lot of support
thanks to the significant investment being made in glycomics research by
governments, businesses, and academic institutions.
Request
For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/glycobiology-market
Another significant factor driving the expansion of the
glycobiology industry is the emergence of glycans as biomarkers. Because
glycans have distinctive structures that can be utilized to diagnose a wide
range of illnesses and syndromes, they have emerged as an important resource
for precision medicine. The market is expanding as a result of the rising
demand for glycan analysis tools and technologies.
Enzymes Segment
Dominates The Global Glycobiology Market
According to type, the glycobiology
market is divided into segments for enzymes, equipment, kits,
carbohydrates, and reagents & chemicals. Enzymes is predicted to be the
largest and fastest-growing section of these throughout the projection period.
Glycosidases, transferases, and other enzymes are the three
sub-segments that make up the segment of enzymes. Complex sugars are broken
down by glycosidases, whilst sugar groups are transferred from one molecule to
another by transferases. The segment is expanding as a result of the rising use
of these enzymes in numerous applications, which are essential for the research
and study of glycans.
Glycobiology
Market Segment By Application: Drug Discovery & Development Takes The Lead
The primary application-based divisions of the glycobiology
market include drug discovery and development, diagnostics, and other
applications.
Due to the growing use of glycans in the creation of new
medications and treatments, the drug discovery and development segment is
anticipated to account for the majority of market growth throughout the
projection period. Glycans are essential for numerous biological activities,
making them an attractive drug discovery target. Research on glycans and their
interactions with other biomolecules is opening up new perspectives on the
creation of medications to treat a range of illnesses and disorders.
Top 10 Leading
Players Dominant In The Global Glycobiology Market
The top 10 players account for a sizeable portion of the
market in the highly concentrated global
glycobiology industry. Some of the major companies profiled in
the report include MERCK KGAA, Agilent Technologies, AMSBIO, Asparia Glycomics,
Bio-Techne, Bruker Corporation, CD Bioglyco, Chemily Glycoscience, Danaher Corporation,
ICE S.P.A., Lectenz Bio, Ludger, New England Biolabs, Promega Corporation,
Shimadzu Corporation, Sumitomo Bakelite, Takara Bio, Thermo Fisher Scientific,
Waters Corporation, and Z Biotech, LLC.
For
More Information about this Report @ https://www.xresearch.biz/shop/glycobiology-market
About
Us: -
xResearch is a market research and consulting organization
that uses unique data, expert analysis, and new technologies to create trusted
intelligence on industries. Our research is focused on delivering an informed
and impartial view on essential market data of industry, and it is primarily
driven by an in-depth study covering the following parameters: Market Sizing
and Forecasting, Market Segmentation, Competitive Analysis, Strategic
Assessment and Business Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-618-4545

Comments
Post a Comment